Atherosclerosis

Article	Citations
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES	227
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON	175
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY	170
IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES	162
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON	131
Integrative prediction models of gestational diabetes mellitus: Insights from lipidomic profiling	124
Inclisiran as monotherapy compared with placebo or ezetimibe in patients at low to borderline atherosclerotic cardiovascular disease risk: Results from the VICTORION-Mono randomized clinical trial	113
Quantitative data comparing LDL results produced by lipid ultracentrifugation with those calculated by the Sampson equation	110
Antibody functionalized lipoprotein complexes (LPC) including a repolarizing drug for the targeted therapy of atherosclerosis	101
Browning of perivascular adipose tissue during early atherosclerosis progression: A contrast to clinical atherosclerosis	98
Low residence time of exogeneous HDL is associated with preserved renal function in rats treated with HgCl2 and accumulation of HDL-protein in adipose tissue	94
Modulating atherosclerotic plaque formation by targeting the plasminogen receptor Plg-RKT	76
The effect of PCSK9 inhibitor treatment on plasma proteome in patients with and without familial hypercholesterolemia	76
Sex-specific impact of the COVID-19 pandemic on metabolic syndrome prevalence	75
Lp(a) levels in individuals with metabolic-dysfunction associated steatotic liver disease	74
18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity	73
Association of traditional cardiometabolic risk factors with atherosclerotic cardiovascular disease in familial hypercholesterolaemia individuals with severe elevation of LDL-cholesterol	68
Levels of C5B-9, RGC-32 and SIRT1 in chronic and acute ischemic coronary artery disease	68
Rates of atherosclerotic cardiovascular events and their management in a longitudinal cohort of dermatomyositis patients with skin involvement	67
Activated and regulatory T-helpers and blood monocytes in patients with HFPEF and type 2 diabetes mellitus	62
Anti-endoglin monoclonal antibody inhibits the progression of liver sinusoidal endothelial inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis	61
Noninvasive parameters of myocardial work and diastolic myocardial function in the assessment of heart failure with preserved ejection fraction in patients with postinfarction cardiosclerosis	60
Clinical phenotypes of patients with stable coronary artery disease, with or without concomitant COVID-19, based on left ventricular function and cerebral blood flow	59
Doxorubicin promotes atherosclerosis in an apolipoprotein e-deficient mouse model, potentially associated with serpina3n	56
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS	55

COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL	55
ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY	55
Rabies vaccine induced microangiopathy	54
Genetic risk score for human serum lipidome and its association with angiographic coronary artery disease	54
IL-21R blockade reduces atherosclerosis development	50
Effect of APOC3 inhibition with volanesorsen on hepatic steatosis in patients with severe hypertriglyceridemia	50
Antagonism of miR-148a attenuates the progression of atherosclerosis in APOBTGApobec-/-Ldlr+/- mice	48
The role of systemic inflammation in reducing the elasticity of the main arteries in patients with chronic heart failure in combination with obesity	46
Methotrexate associated with a lipid core nanoparticle prevented the dilation and dissection of the aortic arch in mice with Marfan syndrome	46
Comparison of cardiovascular prognosis between triglyceride variability and exposure estimate in diabetic patients	46
Effect of high- intensity extremely low frequency magnetic field on the intermediate stage atherosclerotic plaque remodeling: Monitored by histopathology and color doppler ultrasonography	45
Silencing of PCSK9 by SIRNA-functionalized RHDL as tool to upregulate LDLR expression in hepatocytes	45
Regulation of interleukin 1Β drives endothelial-to-mesenchymal transition of valve endothelial cells in patients with aortic valve sclerosis	42
Size, fatty acid and protein characterization of different populations of extracellular vesicles obtained by sequential centrifugation. An useful tool to dissect their biological properties?	41
TREM2 macrophages in adipose tissue and cardiovascular risk	40
Laser- mediated thermal angioplasty of occluded artery accompanied by disulphonated aluminum phthalocyanine - mediated photodynamic therapy combined with catheter- based ruthenium-106 brachytherapy	40
Quality of life in older patients with obesity and chronic kidney disease	39
Targeted proteomics and the presence of carotid plaques in subjects at low cardiovascular disease risk	39
Atherosclerosis in Brazil: An ecological study	39
An upregulation of scube 2 expression in type 2 diabetes mellitus with dyslipidemia	39
Lipid profile assessment as a factor of diabetic nephropathy progression	36
Age- and gender-specific lipid and lipoprotein levels and percentiles from the Thai National Health Examination Survey (NHES-VI) in Thailand	36
The reliability of coronary artery calcium score in symptomatic patients: Questioning the “power of zero”	35
Assessment of the improvement in perfusion after endovascular intervention by hyperspectral imaging	34
Influence of mineral bone disease biomarkers in carotid modeling as a marker of early atherosclerosis in dialysis patients	34
Do triglycerides have an influence on endothelial function detected by Laser Doppler flowmetry?	34
Management of significantly elevated lipoprotein(a) in patients without established ASCVD	34
Reversing the functional- and regenerative capacity of senescent endothelial cells by pharmacological reprogramming	34
Associations of the fatty acids with the concentration of antioxidant enzymes in the blood in men with coronary heart disease	33
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen general population study	33
Does the lipoprotein(A) genotype influence the diagnosis of familial hypercholesterolemia?	33
The impact of cholesterol lowering drugs on metabolism and epigenetics	33
Bioactive lipids and lipoprotein lipase in epicardial adipose tissue from patients with coronary artery disease: Unfolding a missing link	33
Vulnerable atheromatous plaque stabilization using extracorporeal shock wave- mediated sonoporation therapy- assisted HDL and atorvastatin combination therapy	33
The real experience of reaching an extremely low LDL-C level in high risk patients	33
Genome-wide association study on HDL-mediated cholesterol efflux capacity	33
Collaboration of clinic and Biobank as an effective model for dyslipidemia research	32
Effect of B-mode ultrasound- guided extracorporeal low- level focused sonotherapy on early stage atherosclerosis regression using color doppler ultrasonography and histopathology	32
Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium	32
Aging accelerates atherosclerosis development in C57BL/6 mice upon PCSK9 overexpression	32
Coronary computed tomography angiography-derived endothelial shear stress in myocardial bridging	31
Common perinatal characteristics and adverse obstetric complications leading to overweight in adolescence: Assessment of independent and shared maternal-offspring pathways	30
Tetrahydroxystilbene glycoside attenuates endothelial dysfunction and obesity-associated hypertension in obese rats: The role of omentin-1	30
Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolemia: Data from three pooled open-label studies	30
Genetic expression and immunofluorescence mapping of NaV1 highlight potential therapeutic targets in anti-inflammatory treatment of aortic valves stenosis	30
Caspase 8-dependent inhibition of necroptosis prevents plaque necrotic core formation	28
Influence of low glycemic index diet on inflammatory state and lipid parameters in patients with atherosclerotic coronary artery disease	28
Low stenosis low volume carotid artery atherosclerotic plaque for early HI-LLT prescription in first grade cardiovascular prevention	27
CLINICAL AND GENETIC CHARACTERISTICS OF LATE-ONSET LAL DEFICIENCY IN OMAN	27
Circulating large extracellular vesicles from STEMI patients contribute to cardiovascular damage	26

Association between level of depression and coronary heart disease, stroke risk and all-cause and cardiovascular mortality	26
Vascular structural changes in diabetes mellitus patients with chronic kidney disease	26
Illness perception in patients with familial hypercholesterolemia	26
Differences in coronary angiographic findings and outcomes between men and postmenopausal women with chest pain	26
Bempedoic acid efficacy and safety in 7,597 non-diabetic patients, with and without metabolic syndrome, from the randomized, placebo-controlled clear outcomes trial	25
Compensatory metabolic responses in ChREBP-deficient brown adipose tissue	25
The effect of MMP 9, TIMP-1 on the dynamics of cardiac fibrosis in patients with and without coronary artery disease 2 years after renal denervation	25
Severe hypertriglyceridemia and its correlation with clinical atherosclerosis and pancreatitis investigated in beta-quantification	25
miR-148a-3p: A novel therapeutic candidate modulating angiogenesis and senescence for enhanced myocardial infarction recovery – experimental insights and targets explored	25
“Early detection of cardiovascular risk factors in women following gestational diabetes mellitus: A cohort study”	25
Statin treatment reduces long-term risk of revision surgery following total hip arthroplasty in osteoarthritis patients: A registry-based study	25
Risk factors for progressive cardiorenal syndrome in patients with chronic kidney disease: The CRIC study	24
Dissecting sexual dimorphism in aortic valve stenosis by proteomics	24
Rare variants in U2-spliceosome genes are involved in autosomal dominant hypercholesterolemia	24
Circulating monocyte phenotype: A novel biomarker of atherosclerosis	24
Sex differences in the treatment of familial hypercholesterolemia: A systematic review and meta-analysis	24
Machine-learning-based models to predict atherogenic index of plasma range using oculomics and clinic variables in KNHANES for assessing the risk of cardiovascular disease	24
The comparative analyses of combined medicine alpha-lipoic acid and zinc with statins in the treatment of dyslipidemia in patients with atherosclerosis	23
The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia	23
The value of a negative study	23
Residual risk in coronary artery disease: Insights from an observational study	23
Comorbidities, frailty, and prognosis in elderly patients with atrial fibrillation and ischemic heart disease: Insights from a tertiary hospital cohort study	23
Coronary artery calcium: The canary in the coal mine	23
Statin therapy and lipoprotein(a) levels: A systematic review and meta-analysis	23
Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia	22
Fgf23 expression increases atherosclerotic plaque burden in male ApoE deficient mice	22
Corrigendum to “The correlation between medial pattern of intracranial arterial calcification and white matter hyperintensities” [Atherosclerosis 381 (2023) 117247]	22
Editorial Board	22
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study	22
N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus	22
Editorial Board	21
Bivariate relation of vascular health and blood pressure progression during childhood	21
Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction	21
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials	21
Role of fatty acids in the pathogenesis of ß-cell failure and Type-2 diabetes	21
Circular decoys sponge miR-21 and miR-146a in senescent vascular cells	21
Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study	21
Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack	21
Differential associations of constituents of ambient fine particulate matter with 12 cardiovascular diseases: A prospective study	20
Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence	20
Sex differences in LDL-C control in a primary care population: The PORTRAIT-DYS study	20
Haemodynamic and blood viscosity profiles of culprit vs. non-culprit coronary vessels: Insights from NIRS-IVUS and CFD analysis	20
Hepatic Cdkal1 deletion regulates HDL catabolism and promotes reverse cholesterol transport	20
Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program	20
Exercise training-induced plaque stabilization in rabbits associated with restored β2-adrenergic receptor signaling and reduced ectopic trypsin	20
NOD1 ligand FK565 promotes atherogenesis and accumulation of NOD1+ smooth muscle cells in atherosclerotic lesions	19
Beyond quantity: The nonlinear association between HDL cholesterol and coronary atherosclerosis	19
Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation	19
Lp(a) in Argentina: A multicenter study on prevalence and clinical outcomes	19
Gene set analysis of transcriptomics data identifies new biological processes associated with early markers of atherosclerosis but not with those of osteoporosis: Atherosclerosis-osteoporosis co/multi	19
Interplay between epigenetic mechanisms and transcription factors in atherosclerosis	19
Illuminating the full spectrum of APOE variation	19
Metabolomics of aortic valve stenosis: Are aortic valve stenosis and sclerosis different diseases?	19
Galectin-9: A novel promoter of atherosclerosis progression	19
Effect of biological sex on human circulating lipidome: An overview of the literature	19
Repeated measurement of lipoprotein(a): technical versus biological variability	19
Outcome of severe hypertriglyceridemia in hospital practice. A single centre experience from Singapore	18
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)	18
ESTABLISHMENT OF ELISA SYSTEM FOR MODIFIED LDLADIPONECTIN COMPLEX	18
FIRST TIME USE OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, UAE	18
CARDIO-PROTECTIVE ROLE OF ROSMARINIC ACID ON ISOPRENALINE INDUCED CARDIAC DYSFUNCTION	18
GENETIC AND BIOCHEMICAL ANALYSIS OF FOUR JAPANESE SEVERE HYPERTRIGLYCERIDEMIA	18
Editorial Board	18
COMPUTATIONAL IDENTIFICATION OF SMALL MOLECULES FOR MODULATING ATHEROSCLEROSIS AND NAFLD	18
METABOLOMIC ANALYSIS OF KAZAKH PATIENTS WITH METABOLIC SYNDROME BY GC/MS	18
Lysosomal acid lipase (LAL) deficiency alters immune cells distribution in mice and humans	18
LAUNCHOF THE FIRSTHOFH AWARENESS DAY: ADDRESSING UNMET NEEDS	18
ACCURACY OF TROPONIN VALUE IN ELDERLY WITH ACUTE CORONARY SYNDROME	18
UCSCS IN TREATMENT OF T1DM AND T2DM; A META-ANALYSIS	18
Reply to: “Longitudinal studies assessing retinal vascular characteristics in childhood and adolescence must account for ocular growth”	17
A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis	17
The role of antioxidant intake in weight status of children in early adolescence	17
LDL drives the polarized endothelial secretion of fibronectin through syntaxin-4 and syntaxin-6	17
Minigene splicing reporter assay: a high-stake tool for genetic diagnosis in familial hypobetalipoproteinemia	17
Inflammation in COVID-19 is linked to pulmonary embolism and/or vascular tree-in-bud in hospitalized patients. The university hospital of Ioannina COVID-19 Registry, NCT05534074	17
Association of blood lipid profile with 20-year (2002-2022) incidence of cardiovascular disease: The ATTICA study	17
Impact of circulatory microRNA-126 &122 in severity of coronary artery disease correlation with small dense LDL: A case control study	17
Diet quality, front-of-pack labeling, and lipoprotein particle profiles	17
A novel homozygous variant in GPIHBP1 and familial chylomicronemia syndrome in latin America	17
Repurposing statin treatment for the prevention of gallstone disease	17

Low dose interleukin 2 expands plasmablasts with a regulatory b cell phenotype post-MI	17
The role of antiphospholipid antibodies in the onset of myocardial infarction	17
VEGF-A levels and G634c gene polymorphism as a predictor of adverse outcomes in patients with STEMI	16
Investigation of the antioxidant and anti-inflammatory potency of Echinacea angustifolia extract	16
Genetic variation in ADAMTS13 are related to vWF levels, atrial fibrillation and cerebral ischemic events	16
Gender disparities among contemporary patients with acute coronary syndrome: Data from CALLINICUS-hellas registry	16
Empagliflozin prevents human aortic smooth muscle cells damage induced by cholesterol	16
Dyslipidemia and other metabolic alterations in COPD as well as cardiovascular risk in a latin American hospital.	16
The polycomb repressive complex 2 (PRC2) in macrophages and atherosclerosis	16
Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity	16
Mature natural killer type 2 cells and experimental atherosclerosis	16
Plasma concentrations of apolipoproteins and incident cardiovascular diseases in patients with type 2 diabetes	16
Management of hypercolesterolemic subjects at high cardiovascular risk with PCSK9 inhibitors: A “real life” experience in a lipid clinic in sicily	16
Lipoprotein(a) is a predictor of atherogenesis in patients with COPD	16
The interplay between lipoprotein(a) and inflammatory markers in atherosclerotic cardiovascular disease (ASCVD): A focus on neutrophil-to-lymphocyte ratio (NLR)	16
Validation of site-less strategies and long-distance drone-based delivery and collection system to promote access to innovative treatments for patients with rare or severe dyslipidemias	16
LIPC-E97G gain-of-function variant protects from dyslipidemia and atherosclerosis in mice independently of the LDL receptor	16
Post-prandial analysis of fluctuations in the platelet count and platelet activity in patients with the familial chylomicronemia syndrome	16
Heteroplasmy of atherosclerosis-associated mitochondrial DNA mutations and its effects on respiration and viability of cybrids	16
The ceramide- and phosphatidylcholine- based coronary event risk test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes	16
Analysis of total cholesterol and its association with blood pressure, age and northern experience in men 25-54 years working on rotational shifts in the north	16
Variant-specific LDL-cholesterol patterns and risk of atherosclerotic cardiovascular disease in heterozygous FH: Insights from the Austrian FH-Registry	16
Predictors of functional and morphological arterial wall properties in patients with increased lipoprotein (a) before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors	16
Lifestyle and rate of metabolic risk factors in Norwegian patients with a severe mental illness	16
Treatment of vulnerable plaque using combined high-density lipoprotein and pentostatin- loaded microbubbles- mediated shock wave sonoporation therapy: Evaluation with positron emission tomography imag	15
Cardiopulmonary exercise test alterations in young smokers with obesity	15
High and low levels of serum Sirtuin6 in patients with acute ischemic stroke	15
Statin intolerance: What are we overlooking?	15
Protective effect of niclosamide on calcification of aortic valve interstitial cells and its underlying molecular mechanism	15
The patient will see you now: Patient preferences for lipid clinic reviews in a COVID era	15
Myeloid cannabinoid receptor CB1 deficiency limits macrophage proliferation and atherosclerosis in a sex-specific manner	15
The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer	15
Orbital ischemia syndrome in a patient with carotid artery dissection - Case report	15
The condition of the main arteries in patients with chronic heart failure and diabetes mellitus	15
Arterial stiffness and glycometabolic control in older patients with type 2 diabetes	15
Response of lipoproteins to a meal tolerance test in patients with type 2 diabetes and hypertriglyceridemia	15
Polymorphism of DNA repair genes (APEX1 T444G RS1130409) in obese gout patients in the male population of the trans-baikal territory in Russia	15
Prevalence and prognostic impact of lipid goal attainment and patient adherence to lowering lipid treatment: Data from community Italian setting	15
Association of self-reported health and wellbeing indicators with a positive diagnosis for COVID-19. CARTSESIAN-CY study	15
Diagnosis, treatment and cardiovascular outcomes in homozygous familial hypercholesterolaemia: A sex-specific analysis	15
Chronic kidney disease induced atherosclerosis: The regulatory role of mIR-26b	15
An innovative berberine formulation is able to improve bbr bioavailability and the lipid and glycemic profile in HFD-fed mice	15
Epicardial adipose tissue and metabolic markers in dominican type 2 diabetics with preserved cardiac function	15
LPA genotypes and haplotypes influence lipoprotein(a) levels but not arterial wall properties, in stable post-coronary event patients with very high lipoprotein(a) levels	14
Region-specific lipid markers of human carotid atherosclerosis plaque outcome detected by matrix-assisted laser desorption/ionization mass spectrometry imaging	14
Ensemble machine learning for screening cardiovascular diseases in electronic health records	14
The importance of cascade screening of familial hypercholesterolemia in routine clinical practice	14
Double trouble: Pathogenic LDLR and SCARB1 variants in the same family	14
Dietary pattern of elderly people living in the rural area of Mortugaba (BA), Brazil	14
Frequency of variants causing familial hypercholesterolaemia (FH) and impact on LDL-C concentration in individuals of South Asian and African ancestry in the UK Biobank	14
Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages	14
P-selectin as a modulator of fibrin clot properties in patients treated with high-dose statins	14
Protein alterations in VSMCS reveal a defective repairment capacity in thoracic aortic aneurysm associated to BAV	14
New method of calculating low density lipoprotein cholesterol using Korea National Health and Nutrition Examination Survey (KNHANES) and its validation	14
Small LDL subfractions are associated with coronary atherosclerosis	14
Positivity of statin-associated muscle symptoms – Clinical index in a hypertensive population candidated to lipid-lowering therapy but not taking statins	14
Polymorphic assessment of proprotein convertase subtilisin/kexin type 9 (PCSK9) variant rs11591147 in coronary artery disease subjects from Pakistan	14
Association of parental obesity and body mass index in children of patients with early ischemic heart disease	14
Associations of carotenoids, vitamin A and mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study	14
Assessment of atherosclerotic lesions of the carotid arteries depending on the smoking index in patients with coronary artery disease	14
Granzyme B+ CD4+ T cells associate with an unstable plaque phenotype in advanced human atherosclerosis	14
Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey	14
Nutritional approach in paediatric patients with familial hypercholesterolaemia	14
In patients with cardiovascular disease and heart failure dental state (tooth loss) may exacerbate inflammatory syndrome	14
Polygenic risk for future coronary artery disease events in familial hypercholesterolemia	14
Pediatric reference values for non-fasting lipids in French-Canadian children	14
Evidence of proatherogenic inflammation in vascular endothelium of caviae porcellous infected with helicobacter pylori and exposed to high fat diet	13
Effect of Lipoxin-A4 on the glucose challenged monocyte-macrophage axis in early diabetes-associated atherosclerosis	13
Does carotid intima media thickness have a role in predicting genetic familial hypercholesterolaemia?	13
Spring licenses srebp signaling and governs hepatic lipid metabolism and lipoprotein levels in mice and humans	13
Increased values in total cholesterol and LDL cholesterol in “prediabetic” middle-aged and elderly adults with A1C between 5.7 and 6.4%	13
Atherosclerosis burden correlates with acquired pain sensitivity in diversity outbred mice	13
Optimization and validation of lipoprotein(a) KIV2 isoform measurement in patients with familial hypercholesterolemia	13
Genotypic and phenotypic risk factors for atherosclerotic vascular disease in children with familial hypercholesterolemia	13
Impact of endothelial dysfunction on prognosis of coronary heart disease patients	13
Pemafibrate induces atheroprotection in LDLR deficient mice through hepatocyte transrepression PPARA activity	13
Infectious agent as a trigger mechanism of atherosclerosis and сerebrovascular diseases	13
An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia	13
Splenic TFH cell localisation in atherosclerosis	13
Lipid profile and lipoprotein (a) in systemic sclerosis: A systematic review and meta-analysis	13
Treatment effects of ezetimibe in cholesteryl Ester storage disease	13
Vascular wall damage in atherosclerotic cardiovascular disease; Positive effect of extracellular vesicle-based nanotherapeutics on endothelial dysfunction and its key molecular players	13
Sex differences in atherosclerosis lesions and in the response to RAS inhibition in the ApoE-/- MICE	12
Individuals with type 2 diabetes have increased coronary plaque burden and plaque progression during 10-year serial coronary CT angiography follow-up	12
Effect of estimated pulse wave velocity on long-term clinical outcomes in patients with heart failure	12
Docetaxel reduces hepatic lipid accumulation and atherosclerosis	12
Cholesterol treatment trends from 2014-2023 in 3 million US individuals with ASCVD: A retrospective cohort analysis using the family heart database	12
Long-term metabolic effect of the E97G gain-of-function variant of hepatic lipase in high-fat diet fed C57BL6/J mice	12
Ethanol-induced hepatic immune-metabolic dysregulation exacerbates atherosclerosis progression in LDLR-/- mice	12
Epicardial adipose tissue on cardiac MRI and cardiovascular risk: Another reason to watch what you “EAT”	12
Clinical profile of familial hypercholesterolemia phenotype in adults attended in primary care in a large healthcare area	12
Insights into homozygous familial hypercholesterolemia in Portugal	12
Comparative efficacy and safety of different RNA interference therapeutics in the management of hypertension: A systematic review and network meta-analysis of clinical trials	12
Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction	12
Compliance of heterozygous familial hypercholesterolemia patients: 5-years follow-up of the Russian familial hypercholesterolemia registry	12